(Q37776796)

23 August 2017

1 reference

title

Review on anti-lipoprotein lipase antibodies (English)

1 reference

23 August 2017

1 reference

1 reference

2

Eloisa Bonfá

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20673827

14 June 2024

author name string

Carlos Ewerton Maia Rodrigues

1

1 reference

23 August 2017

Jozélio Freire Carvalho

3

1 reference

23 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20673827

14 June 2024

publication date

29 July 2010

1 reference

full work available at URL

23 August 2017

https://doi.org/10.1016/j.cca.2010.07.028

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20673827

https://api.elsevier.com/content/article/PII:S0009898110004870?httpAccept=text/xml

14 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.07.028

https://api.elsevier.com/content/article/PII:S0009898110004870?httpAccept=text/plain

14 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.07.028

14 June 2024

1 reference

23 August 2017

volume

411

1 reference

23 August 2017

issue

21-22

1 reference

23 August 2017

page(s)

1603-1605

1 reference

Autoantibodies to lipoprotein lipase and dyslipidemia in systemic lupus erythematosus

23 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.07.028

Lack of antilipoprotein lipase antibodies in Takayasu's arteritis

14 June 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.07.028

Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?

14 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.07.028

Risk factors for cardiovascular disease in systemic lupus erythematosus

14 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.07.028

Decreased plasma postheparin lipolytic activity in systemic lupus erythematosus

14 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.07.028

Plasma triglyceride determines structure-composition in low and high density lipoproteins

14 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.07.028

Systemic lupus erythematosus and "lupus dyslipoproteinemia".

14 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.07.028

Ausência de anticorpos antilipoproteína lipase na doença de Behçet

14 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.07.028

Dyslipoproteinemia in pediatric systemic lupus erythematosus

14 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.07.028

Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies.

14 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.07.028

Impact of hypertension and hyperhomocysteinemia on arterial thrombosis in primary antiphospholipid syndrome.

14 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.07.028

Low levels of total cholesterol, high-density lipoprotein, and apolipoprotein A1 in association with anticardiolipin antibodies in patients with systemic lupus erythematosus

14 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.07.028

Endothelium activation in the anti-phospholipid syndrome

14 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.07.028

Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo

14 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.07.028

Endothelial activation by aPL: a potential pathogenetic mechanism for the clinical manifestations of the syndrome

14 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.07.028

Direct proinflammatory effect of C-reactive protein on human endothelial cells

14 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.07.028

C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries

14 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.07.028

Characterization of a new case of autoimmune type I hyperlipidemia: long-term remission under immunosuppressive therapy

14 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.07.028

Combination of circulating antilipoprotein lipase (Anti-LPL) antibody and heterozygous S172 fsX179 mutation of LPL gene leading to chronic hyperchylomicronemia

14 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.07.028

14 June 2024

Identifiers

1 reference

23 August 2017

1 reference